Skin Barrier Oral Supplement for Rosacea

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Integrative Skin Science and Research

No Placebo Group

Trial Summary

What is the purpose of this trial?The purpose of this study is to evaluate how supplementation will alter the skin and the gut barrier and inflammation in those with rosacea.

Eligibility Criteria

This trial is for men and women aged 30-70 with mild to moderate rosacea and signs of inflammation (hs-CRP >= 1.0 mg/L). Participants should not have used oral antibiotics or changed hormonal therapies recently, must agree to stop certain supplements and skin treatments before the study, and cannot be pregnant, breastfeeding, or current/recent smokers.

Inclusion Criteria

Your high sensitivity C-reactive protein (hs-CRP) level is 1.0 mg/L or higher.

I am between 30 and 70 years old.

I have mild to moderate rosacea.

Exclusion Criteria

I am willing to stop taking my current supplements 1 month before joining the study.

I stopped taking L-glutamine or supplements containing it a month ago.

I am taking finasteride or dutasteride.

+8 more

Participant Groups

The study tests an oral supplement designed to improve skin barrier function and reduce systemic inflammation in people with rosacea. It aims to see if this supplement can alter both the skin's condition and gut health positively.

1Treatment groups

Experimental Treatment

Group I: Skin Barrier Oral SupplementExperimental Treatment1 Intervention